FeesSafety
Pluang+

Ripple CEO says XRP suits some uses; Ripple may use fiat or RLUSD for others.

Market News
29 Oct 2026, 15:50 WIB
Tokenpost
View Source
Neutral
Ripple CEO says XRP suits some uses; Ripple may use fiat or RLUSD for others.

Ripple CEO Brad Garlinghouse clarified that while XRP is efficient for certain transactions, it may not be ideal for all use cases. For some customer payments, Ripple might opt to use traditional fiat currency or its dollar-backed stablecoin, Ripple USD (RLUSD), instead of XRP. This distinction highlights that XRP's suitability depends on the specific transaction, and Ripple views RLUSD as a complementary option rather than a replacement for XRP. These comments build on Garlinghouse's earlier statements affirming Ripple's commitment to XRP alongside RLUSD.

Ripple CEO Brad Garlinghouse's comments on XRP come with this market snapshot from Pluang as of Oct 29, 2026 20:05 WIB: Among 50 major cryptocurrencies priced on Pluang, 19 rose and 30 fell today. Notable movers include VET at Rp113 with a 1-day change of -2.35% and a typical hold time of 148 days, CAKE at Rp37,225 down 2.27%, and EGLD at Rp62,384 up 2.13%. The most notable figure is VET's 76% buy order activity on Pluang.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
39 minutes ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
39 minutes ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
1 hour ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
1 hour ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App